Cepheid Email Format

Biotechnology Research
5,001-10,000 employees
Sunnyvale, CA, USA

Cepheid is a molecular diagnostics company that develops GeneXpert systems and Xpert tests to deliver rapid, accurate PCR testing for healthcare institutions worldwide.

Find contacts at Cepheid

Search our verified sources for decision-makers, emails, and titles.

Start searching
VERIFIED BY CLAY

first.last@cepheid.com

Company Overview

Industry
Biotechnology Research
Founded
1996
Headquarters
Sunnyvale, CA, USA
Revenue
$1B-$2.5B
FUNDING Stage
Subsidiary
Key Executives
Vitor Rocha (President), Charles Mwangi (Senior Vice President & Chief Financial Officer), James Green (Chief Technology Officer and Vice President R&D)

Tech Stack

commercetools

Infrastructure

Signup

to know

Signup

to know

Signup

to know

Key Executives

Chief Executive Officer

Find the current person →

Chief Finance Officer

Find the current person →

Chief Operating Officer

Find the current person →

Chief Technology Officer

Find the current person →

Chief Marketing Officer

Find the current person →

Chairman

Find the current person →

4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified

Frequently Asked Questions

What is the email format of Cepheid?

Cepheid uses the first.last@cepheid.com format on cepheid.com, so Jane Smith would be jane.smith@cepheid.com.

Where is Cepheid headquartered and what does the company do?

Cepheid is headquartered in Sunnyvale, CA, and is a molecular diagnostics company that develops the GeneXpert platform along with a broad menu of Xpert tests covering infectious diseases, oncology, sexual health, and healthcare-associated infections.

How can I find and verify a Cepheid contact for my outreach?

Since Cepheid uses the first.last@cepheid.com pattern, you can build and verify addresses for specific contacts using a tool like Clay to confirm deliverability before reaching out to their sales, R&D, or clinical teams.

What diseases does Cepheid's Global Access Program target in low- and middle-income countries?

Cepheid's Global Access Program, launched in 2011, provides subsidized molecular testing for tuberculosis, HIV, Hepatitis C, HPV, and Ebola, with more than 20,000 GeneXpert systems installed across high-burden developing countries.

Who leads Cepheid's technology and R&D efforts?

James Green serves as Chief Technology Officer and Vice President of R&D at Cepheid, overseeing technology development for the company's GeneXpert systems and Xpert test menu.

Share Article

Get access to more people and company data using Clay

Leverage the power of 100+ data providers for industry-leading data coverage & quality.

4.9 rating

More Articles